PPARA and metabolic dysfunction-associated steatohepatitis: Wy14,643, a PPARα gene agonist, improved steatosis and ballooning in diabetic NASH model mice [30], and a dual PPARα/δ agonist exerted liver-protective effects on steatosis, inflammation, and fibrosis in several rodent models [31].